- Page 1 and 2: (19)(11) EP 1 694 829 B1(12) FASCIC
- Page 3 and 4: EP 1 694 829 B1Description510152025
- Page 5 and 6: EP 1 694 829 B15101520253035[0026]
- Page 7 and 8: EP 1 694 829 B151015202530354045505
- Page 9 and 10: EP 1 694 829 B151015202530354045505
- Page 11 and 12: EP 1 694 829 B151015non-humains, le
- Page 13 and 14: EP 1 694 829 B15101520253035404550c
- Page 15: EP 1 694 829 B151015[0144] Les Inve
- Page 19 and 20: EP 1 694 829 B151015comme anticorps
- Page 21 and 22: EP 1 694 829 B15101520A.Des groupes
- Page 23 and 24: EP 1 694 829 B151015202530sérums d
- Page 25 and 26: 2. Amplification, séquençage et c
- Page 27 and 28: EP 1 694 829 B1555°C, 2 min à 94
- Page 29 and 30: EP 1 694 829 B151015CoV issue du pr
- Page 31 and 32: EP 1 694 829 B1(suite)5REGIONAMPLIF
- Page 33 and 34: EP 1 694 829 B15tidique par rapport
- Page 35 and 36: EP 1 694 829 B11) Matériela) lysat
- Page 37 and 38: EP 1 694 829 B1et THUMBUP (Zhou et
- Page 39 and 40: EP 1 694 829 B1pendant une nuit. La
- Page 41 and 42: EP 1 694 829 B15101520253035404550T
- Page 43 and 44: EP 1 694 829 B1c) mise au point de
- Page 45 and 46: EP 1 694 829 B1(suite)572°C 30 sec
- Page 47 and 48: EP 1 694 829 B15101520253035Tableau
- Page 49 and 50: EP 1 694 829 B1510Les solutions (mo
- Page 51 and 52: EP 1 694 829 B151015202530354045oli
- Page 53 and 54: EP 1 694 829 B151015"de base" TRIP-
- Page 55 and 56: EP 1 694 829 B15101520(différence
- Page 57 and 58: EP 1 694 829 B151015(suite)groupe s
- Page 59 and 60: EP 1 694 829 B151015Tableau XV : ut
- Page 61 and 62: EP 1 694 829 B15101520253035404550q
- Page 63 and 64: EP 1 694 829 B16) Autres applicatio
- Page 65 and 66: EP 1 694 829 B1forme soluble (Ssol)
- Page 67 and 68:
EP 1 694 829 B151015202530354045505
- Page 69 and 70:
EP 1 694 829 B151015202530354045505
- Page 71 and 72:
EP 1 694 829 B151015202530354045505
- Page 73 and 74:
EP 1 694 829 B151015202530354045505
- Page 75 and 76:
EP 1 694 829 B151015202530354045505
- Page 77 and 78:
EP 1 694 829 B151015202530354045505
- Page 79 and 80:
EP 1 694 829 B151015202530354045505
- Page 81 and 82:
EP 1 694 829 B15101520253035404550<
- Page 83 and 84:
EP 1 694 829 B151015202530354045505
- Page 85 and 86:
EP 1 694 829 B151015202530354045505
- Page 87 and 88:
EP 1 694 829 B1<212> PRT<213> CORON
- Page 89 and 90:
EP 1 694 829 B151015202530354045505
- Page 91 and 92:
EP 1 694 829 B151015202530354045505
- Page 93 and 94:
EP 1 694 829 B151015202530354045505
- Page 95 and 96:
EP 1 694 829 B1<400> 55101520253035
- Page 97 and 98:
EP 1 694 829 B1510152025<210> 7<211
- Page 99 and 100:
EP 1 694 829 B151015202530354045505
- Page 101 and 102:
EP 1 694 829 B1510152025303540<210>
- Page 103 and 104:
EP 1 694 829 B15101520253035<210> 1
- Page 105 and 106:
EP 1 694 829 B1510<210> 16<211> 708
- Page 107 and 108:
EP 1 694 829 B15101520<210> 18<211>
- Page 109 and 110:
EP 1 694 829 B15101520253035<210> 2
- Page 111 and 112:
EP 1 694 829 B15<220><221> CDS<222>
- Page 113 and 114:
EP 1 694 829 B15101520253035404550<
- Page 115 and 116:
EP 1 694 829 B1510152025<210> 28<21
- Page 117 and 118:
EP 1 694 829 B1510152025<210> 31<21
- Page 119 and 120:
EP 1 694 829 B151015202530354045505
- Page 121 and 122:
EP 1 694 829 B151015202530354045505
- Page 123 and 124:
EP 1 694 829 B151015202530354045505
- Page 125 and 126:
EP 1 694 829 B151015202530354045505
- Page 127 and 128:
EP 1 694 829 B151015202530354045505
- Page 129 and 130:
EP 1 694 829 B15<210> 35<211> 70<21
- Page 131 and 132:
EP 1 694 829 B1510152025303540<210>
- Page 133 and 134:
EP 1 694 829 B1510152025<210> 38<21
- Page 135 and 136:
EP 1 694 829 B1510<210> 41<211> 448
- Page 137 and 138:
EP 1 694 829 B151015202530354045505
- Page 139 and 140:
EP 1 694 829 B15101520253035<210> 4
- Page 141 and 142:
EP 1 694 829 B15101520253035404550<
- Page 143 and 144:
EP 1 694 829 B1<213> CORONAVIRUS<40
- Page 145 and 146:
EP 1 694 829 B1510152025<210> 51<21
- Page 147 and 148:
EP 1 694 829 B1510152025303540<210>
- Page 149 and 150:
EP 1 694 829 B151015202530354045505
- Page 151 and 152:
<211> 16<212> DNA<213> amorce antis
- Page 153 and 154:
EP 1 694 829 B1<212> DNA<213> CORON
- Page 155 and 156:
EP 1 694 829 B151015202530354045505
- Page 157 and 158:
EP 1 694 829 B151015202530354045505
- Page 159 and 160:
EP 1 694 829 B151015202530354045505
- Page 161 and 162:
EP 1 694 829 B151015202530354045505
- Page 163 and 164:
EP 1 694 829 B151015202530354045505
- Page 165 and 166:
EP 1 694 829 B151015202530354045505
- Page 167 and 168:
EP 1 694 829 B151015202530354045505
- Page 169 and 170:
EP 1 694 829 B151015202530354045505
- Page 171 and 172:
EP 1 694 829 B151015202530354045505
- Page 173 and 174:
EP 1 694 829 B151015202530354045505
- Page 175 and 176:
EP 1 694 829 B151015202530354045505
- Page 177 and 178:
EP 1 694 829 B151015202530354045505
- Page 179 and 180:
EP 1 694 829 B151015202530354045505
- Page 181 and 182:
EP 1 694 829 B1510152025<210> 76<21
- Page 183 and 184:
EP 1 694 829 B1<223> amorce S/L5/+/
- Page 185 and 186:
EP 1 694 829 B1<211> 20<212> DNA<21
- Page 187 and 188:
EP 1 694 829 B1<400> 105ctaaaccttg
- Page 189 and 190:
EP 1 694 829 B1<213> Artificial seq
- Page 191 and 192:
EP 1 694 829 B1cacgtggttg aatgacttt
- Page 193 and 194:
EP 1 694 829 B1<220><223> amorce SA
- Page 195 and 196:
EP 1 694 829 B151015202530354045505
- Page 197 and 198:
EP 1 694 829 B151015202530354045505
- Page 199 and 200:
EP 1 694 829 B1<212> DNA<213> Artif
- Page 201 and 202:
EP 1 694 829 B1<211> 53<212> DNA<21
- Page 203 and 204:
EP 1 694 829 B17. Use of a product
- Page 205 and 206:
EP 1 694 829 B1205
- Page 207 and 208:
EP 1 694 829 B1207
- Page 209 and 210:
EP 1 694 829 B1209
- Page 211 and 212:
EP 1 694 829 B1211
- Page 213 and 214:
EP 1 694 829 B1213
- Page 215 and 216:
EP 1 694 829 B1215
- Page 217 and 218:
EP 1 694 829 B1217
- Page 219 and 220:
EP 1 694 829 B1219
- Page 221 and 222:
EP 1 694 829 B1221
- Page 223 and 224:
EP 1 694 829 B1223
- Page 225 and 226:
EP 1 694 829 B1225
- Page 227 and 228:
EP 1 694 829 B1227
- Page 229 and 230:
EP 1 694 829 B1229
- Page 231 and 232:
EP 1 694 829 B1231
- Page 233 and 234:
EP 1 694 829 B1233
- Page 235 and 236:
EP 1 694 829 B1235
- Page 237 and 238:
EP 1 694 829 B1237
- Page 239 and 240:
EP 1 694 829 B1239
- Page 241 and 242:
EP 1 694 829 B1241
- Page 243 and 244:
EP 1 694 829 B1243
- Page 245 and 246:
EP 1 694 829 B1245
- Page 247 and 248:
EP 1 694 829 B1247
- Page 249 and 250:
EP 1 694 829 B1249
- Page 251 and 252:
EP 1 694 829 B1251
- Page 253 and 254:
EP 1 694 829 B1253
- Page 255 and 256:
EP 1 694 829 B1255
- Page 257 and 258:
EP 1 694 829 B1257
- Page 259 and 260:
EP 1 694 829 B1259
- Page 261 and 262:
EP 1 694 829 B1261
- Page 263 and 264:
EP 1 694 829 B1263
- Page 265 and 266:
EP 1 694 829 B1265
- Page 267 and 268:
EP 1 694 829 B1267
- Page 269 and 270:
EP 1 694 829 B1269
- Page 271 and 272:
EP 1 694 829 B1271
- Page 273 and 274:
EP 1 694 829 B1273
- Page 275 and 276:
EP 1 694 829 B1275
- Page 277 and 278:
EP 1 694 829 B1277
- Page 279 and 280:
EP 1 694 829 B1279
- Page 281 and 282:
EP 1 694 829 B1281
- Page 283 and 284:
EP 1 694 829 B1283
- Page 285 and 286:
EP 1 694 829 B1285
- Page 287 and 288:
EP 1 694 829 B1287
- Page 289 and 290:
EP 1 694 829 B1289
- Page 291 and 292:
EP 1 694 829 B1291
- Page 293 and 294:
EP 1 694 829 B1293
- Page 295 and 296:
EP 1 694 829 B1295
- Page 297 and 298:
EP 1 694 829 B1297
- Page 299 and 300:
EP 1 694 829 B1299
- Page 301 and 302:
EP 1 694 829 B1301
- Page 303 and 304:
EP 1 694 829 B1303
- Page 305 and 306:
EP 1 694 829 B1305
- Page 307 and 308:
EP 1 694 829 B1307
- Page 309 and 310:
EP 1 694 829 B1309
- Page 311 and 312:
EP 1 694 829 B1311
- Page 313 and 314:
EP 1 694 829 B1313
- Page 315 and 316:
EP 1 694 829 B1315
- Page 317 and 318:
EP 1 694 829 B1317
- Page 319 and 320:
EP 1 694 829 B1319